GMED vs MASI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 06, 2026

GMED

56.0
AI Score
VS
MASI Wins

MASI

60.4
AI Score

Investment Advisor Scores

GMED

56score
Recommendation
HOLD

MASI

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric GMED MASI Winner
Forward P/E 16.7224 40.8163 GMED
PEG Ratio 1.7253 4.8334 GMED
Revenue Growth 27.0% 8.5% GMED
Earnings Growth 66.7% 214.4% MASI
Tradestie Score 56.0/100 60.4/100 MASI
Profit Margin 18.9% 4.9% GMED
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY MASI

Frequently Asked Questions

Based on our detailed analysis, MASI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.